amantadine and dihydroxyphenylalanine

amantadine has been researched along with dihydroxyphenylalanine in 189 studies

Research

Studies (189)

Timeframe	Studies, this research(%)	All Research%
pre-1990	185 (97.88)	18.7374
1990's	3 (1.59)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (0.53)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bellman, K; Knegtel, RM; Settimo, L	1
Pradhan, SN	1
Gehlen, W	2
Barbeau, A; Gonce, M	1
Diehl, LW	1
Iadgarov, IS; Kandel', EI	1
Baker, J; Iversen, LL; Iversen, SD; Pilling, JB; Robbins, T	1
Andrezinia, RA; Kamianov, IM	1
Davis, JM; Janicak, PG; Sakkas, P; Wang, ZY	1
Baxter, RC; Curzon, G; Knill-Jones, RP; Knott, PJ; Marsden, CD; Parkes, JD; Tattersall, R; Vollum, D	1
Baxter, RC; Marsden, CD; Parkes, JD; Zilkha, KJ	1
Bricolo, A; Puca, FM; Turella, G	2
Moore, KE; Von Voigtlander, PF	1
Bianchi, C; Tomasi, L	1
Consolo, S; Garattini, S; Ladinsky, H	1
Soyka, D	1
Gressier, H; Malecot, E; Poignant, JC	1
Casacchia, M; Fieschi, C; Nardini, M; Tedone, ME	1
Scotti, G	1
Casacchia, M; Fieschi, C; Nardini, M; Reitano, M; Robotti, E; Tedone, ME	1
Bergmann, S; Frears, CC; Godwin-Austen, RB; Knill-Jones, RP; Parkes, JD	1
Armitage, P; Hunter, KR; Laurence, DR; Stern, GM	1
Espir, ML; Hasan, I; Millac, P; Slyfield, DG	1
Herson, RN	1
Candelise, L; Faglioni, P; Spinnler, H; Vignolo, LA	1
Ilahi, MM; Klawans, H; Shenker, D	1
Bird, MT; Paulson, GW	1
Di Perri, R; Livrea, P; Messina, C; Puca, FM; Tomasello, F	1
Avery, GS; Brogden, RN; Speight, TM	1
Di Rosa, AE; Messina, C; Tomasello, F	1
Andrews, C; Lance, JW	1
Ambrozi, L; Birkmayer, W; Danielczyk, W; Neumayer, E; Riederer, P	1
Greer, M	1
Strömberg, U; Svensson, TH	1
Stromberg, U; Svensson, TH; Waldeck, B	1
Shibasaki, H	1
Shimomura, SK	1
Shibazaki, H	1
Durek, B; Maj, J; Palider, W	1
Calne, DB; Reid, JL	1
Young, RR	1
Beck, H; Matsumoto, K; Omoto, T	1
Kadzielawa, K	1
Howes, J; Osgood, P	1
Cooper, P	1
Andrews, CJ	1
Fehling, C	2
Kytomaki, O; Nousiainen, R; Pekkarinen, A; Rinne, U; Siirtola, T; Sonninen, V; Viljanen, M	1
Duvoisin, RC; Yahr, MD	1
Wanger, SL	1
Rinne, UK; Siirtola, T; Sonninen, V	1
Allen, F; Dallos, V; Heathfield, K; Stone, P	1
Ngai, SH	1
Hodkinson, HM	1
Jorgensen, PB; Pollock, M	1
Ferrari, P; Robotti, E	1
Dupont, E	1
Grégoire, J; Raymondeaud, C; Sigwald, J	1
Calne, DB; Hilson, A; Rao, SK; Vakil, SD	1
Benesová, O	1
Tolosa, E	1
Rinne, UK	1
Hamoen, AM	1
Hubermann, J; Zeldowicz, LR	1
Albers, JW; Henderson, WG; Potvin, AR; Repa, BS; Stribley, RF; Tourtellotte, WW; Walker, JE	1
Iivanainen, M	2
Grossmann, W; Jurna, I; Nell, T; Ruzdić, N	1
Blomberg, LH	1
Strömberg, U; Svensson, T	1
Gilland, O	1
Meyerson, B	1
Glass, J	1
Jones, DG; Lenman, JA; Robertson, MA; Turnbull, MJ	2
Rivera-Calimlim, L	1
Degos, CF; Lhermitte, F	1
Debeus, R; Gaetani, M	1
Bulandra, R; Ciuca, I; Ninosu, N; Serbanesco, A	1
England, AC; Poskanzer, DC; Schwab, RS; Young, RR	2
Bauer, RB; Reveno, WS; Rosenbaum, H	2
Pakkenberg, H	1
Korduba, CA; Symchowicz, S; Veals, J	1
Barnett, A; Fiore, JW	1
Cox, B; Danta, G; Schnieden, H; Yuill, GM	1
Birkmayer, W; Danielcyk, W; Neumayer, E; Riederer, P	1
Kytömäki, O; Nousiainen, R; Pekkarinen, A; Rinne, UK; Viljanen, M	1
Davis, RL; Wolf, SM	1
Berio, A; Di Stefano, A; Vento, R	1
Brait, K; Fahn, S; Schwarz, GA	1
Cashin, CH; Sutton, S	1
Weinmann, RL	1
Oppel, F; Umbach, W	1
Hirschmann, J	1
Svensson, TH	1
Bianchine, JR; Messiha, FS; Peaston, MJ	1
Siegfried, J	1
Danielczyk, W	1
Camanni, F; Massara, F; Molinatti, GM	1
Bulandra, R; Cincă, I; Ninosu, N; Serbănesco, A	1
Hackman, R; Neuvonen, PJ; Pentikainen, P; Vapaatalo, H	1
Presthus, J	1
Brmalj, V; Cvetnić, S; Srebocan, S; Stern, P	1
Fodor, A; Molnár, G	1
Paini, GP; Passoni, M	1
Cox, B; Tha, SJ	1
Papeschi, R; Randrup, A	1
Lampert, PW; London, GW; Powell, HC	1
Chase, TN; Glaubiger, GA; Woods, AC	1
Fischer, PA; Jacobi, P; Schneider, E	1
Baxter, RC; Marsden, CD; Parkes, JD; Rees, JE	1
Davies, JA; Jackson, B; Redfern, PH	1
Green, HD; Pearce, LA; Waterbury, LD	1
Bauer, RB; McHenry, JT	1
Delwaide, PJ; Schwab, RS; Young, RR	1
Mercier, DA; Shealy, CN; Weeth, JB	1
England, AC; Schwab, RS	1
Baxter, R; Clements, PJ; Knill-Jones, RP; Parkes, JD; Zilkha, KJ	1
Piot, C; Raymondeaud, C; Sigwald, J	1
Barbeau, A; Botez, MI; Joubert, M; Mars, H	1
Mann, DC; Pearce, LA; Waterbury, LD	1
Albert, E	1
Gambacorta, D; Giuffrè, R	2
Pearce, I; Pearce, J	1
Boudin, G; Guillard, A; Pépin, B	1
Castaigne, P; Dordain, G; Laplane, D	1
Gurtner, B; Hacohen, H	1
Jameson, HD	1
Sigwald, J	1
Raymondeaud, C; Sigwald, J	1
Critchley, E	2
Kamińska, A; Marciniak, M; Mrozek, K	1
Gerstenbrand, F; Gründig, E; Musiol, A	1
Baran, L; Maj, J; Sowińska, H	1
Castaigne, P; Ribadeau-Dumas, JL; Rondot, P	1
Ferel, D	1
Vecchi, L	1
Danielczyk, W; Korten, JJ	1
Monaco, V; Montanari, M; Robotti, CA	1
Ferraris, M	1
Buscaino, GA; Campanella, G; Zallone, E	1
Caliri, F; Di Rosa, AE; Meduri, M; Megna, G; Musolino, R; Scuderi, D	1
Barbieri, NF; Megna, GF; Micalizzi, V; Pigneri, MT; Puca, FM	1
Cerillo, A; D'Andrea, F; De Divitiis, E; Signorelli, CD	2
Kluzer, G; Lampo, B	1
Ambrosetto, C; Martinelli, P	1
Paciaroni, E; Raspa, EG; Saccomanno, G	1
Casacchia, M; Fieschi, C; Nardini, M; Reitano, N	1
Schott, B	2
Birkmayer, W	1
Hartmann-von Monakow, K	1
Florio, V; Longo, VG	1
Florio, V	1
Delwaide, PJ; Penders, CA	1
Schwab, RS; Young, RR	1
Tubaro, E	1
Broggi, G; Fasano, VA; Urciuoli, R	1
Völler, GW	1
Green, J	1
Jenkins, AC; Schwieger, AC	1
Delwaide, PJ; Penders, C; Waltregny, A	1
Kapp, W; Völler, GW	1
Clements, PJ; Knill-Jones, RP; Parkes, JD	1
Tegeler, J; Wöller, W	1
Spoerlein, MT; Vallano, ML; VanderWende, C	1
Uono, M	1
Borisova, NV; Kaplun, AP; Kriukov, VI; Shvets, VI	1
Cumming, P; Dagher, A; Deep, P; Gjedde, A; Sadikot, A	1

Reviews

22 review(s) available for amantadine and dihydroxyphenylalanine

Article	Year
Aggression and central neurotransmitters. International review of neurobiology, 1975, Volume: 18 Topics: Acetylcholinesterase; Aggression; Amantadine; Animals; Apomorphine; Brain; Carbachol; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine beta-Hydroxylase; Humans; Hydroxydopamines; Hydroxyindoleacetic Acid; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parasympatholytics; Pimozide; Tubocurarine	1975
[Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases]. Medizinische Klinik, 1977, Aug-12, Volume: 72, Issue:32-33 Topics: Amantadine; Anticonvulsants; Barbiturates; Benzodiazepines; Carbamazepine; Central Nervous System Diseases; Cerebrovascular Disorders; Chemical Phenomena; Chemistry; Contraceptives, Oral; Dihydroxyphenylalanine; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydantoins; Mental Disorders; Nervous System Diseases; Parasympatholytics; Parkinson Disease; Pregnancy; Succinimides	1977
[The current treatment of Parkinson's disease]. Revue medicale de Liege, 1976, Oct-10, Volume: 31, Issue:19 Topics: Amantadine; Antidepressive Agents, Tricyclic; Dihydroxyphenylalanine; Drug Combinations; Histamine Antagonists; Humans; Levodopa; Mental Disorders; Movement Disorders; Neurosecretory Systems; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Pyridoxine; Stereotaxic Techniques	1976
Theoretical implications of the use of L-dopa in parkinsonism. A review. Acta neurologica Scandinavica, 1970, Volume: 46, Issue:4 Topics: Acetylcholine; Amantadine; Animals; Cats; Dihydroxyphenylalanine; Dopamine; Female; Haplorhini; Humans; Injections, Intravenous; Male; Movement Disorders; Parkinson Disease; Serotonin; Substantia Nigra; Synaptic Transmission	1970
Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism. Drugs, 1971, Volume: 2, Issue:4 Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Basal Ganglia Diseases; Brain Chemistry; Cats; Depression; Dihydroxyphenylalanine; Dogs; Dopamine; Drug Interactions; Guinea Pigs; Haplorhini; Humans; Mice; Movement Disorders; Parasympatholytics; Parkinson Disease; Rabbits; Rats; Synaptic Transmission	1971
[Biochemical aspects of human behavior]. Wiener Zeitschrift fur Nervenheilkunde und deren Grenzgebiete, 1973, Volume: 31, Issue:3 Topics: Amantadine; Behavior; Biogenic Amines; Brain; Depression; Dihydroxyphenylalanine; Dopamine; Epinephrine; Humans; Neurasthenia; Norepinephrine; Obsessive-Compulsive Disorder; Parkinson Disease; Psychoses, Substance-Induced; Serotonin; Synaptic Transmission	1973
Parkinson's syndrome. Recent progress in the medical treatment and its pharmacological basis. Minnesota medicine, 1971, Volume: 54, Issue:10 Topics: Amantadine; Atropine; Catecholamines; Dihydroxyphenylalanine; Histamine H1 Antagonists; Humans; Imipramine; Parkinson Disease; Tryptophan	1971
[Recent advances and pharmacological basis of the medical treatment of Parkinson's syndrome]. Shinkei kenkyu no shimpo. Advances in neurological sciences, 1971, Volume: 15, Issue:4 Topics: Amantadine; Catecholamines; Dihydroxyphenylalanine; Histamine H1 Antagonists; Humans; Imipramine; Parasympatholytics; Parkinson Disease; Tryptophan	1971
Antiparkinsonian drugs: pharmacological and therapeutic aspects. Drugs, 1972, Volume: 4, Issue:1 Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Histamine H1 Antagonists; Humans; Mental Disorders; Methyldopa; Movement Disorders; Norepinephrine; Parasympatholytics; Serotonin; Synaptic Transmission	1972
Drug therapy of parkinsonism. The New England journal of medicine, 1972, Jul-06, Volume: 287, Issue:1 Topics: Amantadine; Amitriptyline; Amphetamine; Antiparkinson Agents; Dihydroxyphenylalanine; Drug Antagonism; Drug Synergism; Humans; Imipramine; Methyldopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Phenothiazines	1972
The management of Parkinson's syndrome. The Medical clinics of North America, 1972, Volume: 56, Issue:3 Topics: Adult; Aged; Amantadine; Benztropine; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Female; Humans; Hydrazines; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Psychotherapy; Stereotaxic Techniques; Thalamus; Thinking	1972
Parkinsonism, levodopa, and anesthesia. Anesthesiology, 1972, Volume: 37, Issue:3 Topics: Amantadine; Anesthesia; Animals; Apomorphine; Benperidol; Blood-Brain Barrier; Brain; Cardiovascular Diseases; Catecholamines; Dihydroxyphenylalanine; Dopamine; Fentanyl; Humans; Mice; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Pulmonary Edema; Rats	1972
Advances in geriatrics. The Practitioner, 1972, Volume: 209, Issue:252 Topics: Aged; Amantadine; Diet Therapy; Dihydroxyphenylalanine; Diverticulum, Colon; Drug-Related Side Effects and Adverse Reactions; Geriatrics; Humans; Hyperthyroidism; Medication Errors; Myocardial Infarction; Myxedema; Parkinson Disease; Thyroid Diseases	1972
[Parkinsonism. Therapeutic, pathophysiological, pharmacological and biochemical aspects]. Ugeskrift for laeger, 1973, Jan-15, Volume: 135, Issue:3 Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Central Nervous System; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease; Physical Therapy Modalities; Stereotaxic Techniques	1973
Augmenting the action of levodopa. Postgraduate medical journal, 1972, Volume: 48, Issue:565 Topics: Amantadine; Antacids; Apomorphine; Carboxy-Lyases; Catechol O-Methyltransferase Inhibitors; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Drug Synergism; Humans; Methyldopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease	1972
[Review of current pharmacotherapy of Parkinsonism. Comprehensive review]. Ceskoslovenska neurologie, 1973, Volume: 36, Issue:3 Topics: 5-Hydroxytryptophan; Amantadine; Anticonvulsants; Apomorphine; Benztropine; Carboxy-Lyases; Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease; Procyclidine; Trihexyphenidyl	1973
Parkinson's disease; modern treatment. Minnesota medicine, 1973, Volume: 56, Issue:6 Topics: Amantadine; Amphetamine; Antidepressive Agents; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Catechol O-Methyltransferase Inhibitors; Desipramine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Combinations; Drug Incompatibility; Drug Synergism; Humans; Imipramine; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease	1973
Recent advances in the treatment of Parkinsonism with drugs. Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51 Topics: Amantadine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Arrhythmias, Cardiac; Blood-Brain Barrier; Brain; Central Nervous System; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Drug Tolerance; Humans; Hydrazines; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Rats; Time Factors; Vomiting	1972
Quantitative evaluation of neuropharmacological trials. Clinical pharmacology and therapeutics, 1974, Volume: 15, Issue:3 Topics: Activities of Daily Living; Age Factors; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Fatigue; Humans; Learning Disabilities; Motor Skills; Multiple Sclerosis; Nervous System Diseases; Neurologic Examination; Neurologic Manifestations; Parkinson Disease; Time Factors; Tremor	1974
Use of drugs in the treatment of parkinsonism. Nutrition reviews, 1970, Volume: 28, Issue:1 Topics: Amantadine; Depression; Dihydroxyphenylalanine; Feeding and Eating Disorders; Humans; Hypertension; Nausea; Parkinson Disease; Sleep Initiation and Maintenance Disorders	1970
[Therapy and problems of parkinsonism]. Der Nervenarzt, 1971, Volume: 42, Issue:5 Topics: Adult; Aged; Amantadine; Animals; Antidepressive Agents; Apomorphine; Brain Chemistry; Brain Stem; Dihydroxyphenylalanine; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Stereotaxic Techniques; Sympathomimetics	1971
Current concepts of Parkinsonism. Postgraduate medical journal, 1971, Volume: 47, Issue:554 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease; Stereotaxic Techniques	1971

Trials

31 trial(s) available for amantadine and dihydroxyphenylalanine

Article	Year
Plasma concentrations of L-dopa and 3-methoxydopa and improvement in clinical ratings and motor performance in patients with Parkinsonism treated with L-dopa alone or in combination with amantadine. Journal of neurology, neurosurgery, and psychiatry, 1975, Volume: 38, Issue:2 Topics: Activities of Daily Living; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Disability Evaluation; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Motor Skills; Parkinson Disease; Time Factors	1975
Amantadine in migraine. Lancet (London, England), 1972, Aug-26, Volume: 2, Issue:7774 Topics: Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Migraine Disorders; Parkinson Disease; Placebos	1972
Effect of L-dopa or amantadine therapy on sleep spindles in Parkinsonism. Electroencephalography and clinical neurophysiology, 1973, Volume: 35, Issue:3 Topics: Action Potentials; Adult; Aged; Amantadine; Dihydroxyphenylalanine; Electroencephalography; Electromyography; Female; Humans; Male; Middle Aged; Parkinson Disease; Sleep; Sleep, REM	1973
Amantadine for Parkinson's disease. Lancet (London, England), 1970, May-02, Volume: 1, Issue:7653 Topics: Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Parkinson Disease; Placebos	1970
Amantadine versus L-2 dopa and amatadine plus L-dopa. Lancet (London, England), 1970, Jul-18, Volume: 2, Issue:7664 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1970
Combined treatment of parkinsonism with L-dopa and amantadine. Lancet (London, England), 1970, Aug-22, Volume: 2, Issue:7669 Topics: Aged; Amantadine; Chorea; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Hypotension; Male; Middle Aged; Muscle Tonus; Nausea; Parkinson Disease; Parkinson Disease, Postencephalitic; Placebos; Time Factors; Vomiting	1970
Combined treatment of parkinsonism with L-dopa and amantadine. Lancet (London, England), 1970, Sep-12, Volume: 2, Issue:7672 Topics: Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Parkinson Disease; Placebos	1970
Treatment of Parkinsonism with L-dopa and amantadine. Lancet (London, England), 1970, Oct-03, Volume: 2, Issue:7675 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease; Placebos	1970
Letter: Treatment of Huntington's chorea. The New England journal of medicine, 1973, Nov-29, Volume: 289, Issue:22 Topics: Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Clinical Trials as Topic; Diazepam; Dihydroxyphenylalanine; Drug Therapy, Combination; Haloperidol; Humans; Huntington Disease; Hydrazines; Reserpine	1973
Administration of amandine to patients on optimum L-dopa dosage. Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51 Topics: Amantadine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Parkinson Disease; Placebos; Surveys and Questionnaires; Time Factors	1972
Treatment of Parkinson's disease with amantadine and L-Dopa. European neurology, 1972, Volume: 7, Issue:4 Topics: Adult; Aged; Alkaline Phosphatase; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Combinations; Drug Synergism; Female; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Parkinson Disease; Phenylacetates; Placebos; Prognosis	1972
The comparative value of amantadine and levodopa. Postgraduate medical journal, 1972, Volume: 48, Issue:560 Topics: Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Middle Aged; Parkinson Disease	1972
Combined L-dopa and amantadine in Parkinsonism. Australian and New Zealand journal of medicine, 1972, Volume: 2, Issue:3 Topics: Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos	1972
[Clinical evaluation of the drugs and quantitative nosography]. Bollettino chimico farmaceutico, 1972, Volume: 111, Issue:9 Topics: Amantadine; Biopharmaceutics; Clinical Trials as Topic; Dihydroxyphenylalanine; Evaluation Studies as Topic; Humans; Parkinson Disease; Therapeutic Equivalency	1972
[Treatment of Parkinson's disease with amantadine]. Therapeutique (La Semaine des hopitaux), 1972, Volume: 48, Issue:9 Topics: Administration, Oral; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Synergism; Humans; Parkinson Disease; Placebos; Prognosis	1972
The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome. Acta neurologica Scandinavica, 1973, Volume: 49, Issue:2 Topics: Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Substance Withdrawal Syndrome	1973
Long-term therapy of Parkinson's disease with amantadine, alone and combined with levodopa. Canadian Medical Association journal, 1973, Oct-06, Volume: 109, Issue:7 Topics: Activities of Daily Living; Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Placebos; Time Factors	1973
Quantitative evaluation of neuropharmacological trials. Clinical pharmacology and therapeutics, 1974, Volume: 15, Issue:3 Topics: Activities of Daily Living; Age Factors; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Fatigue; Humans; Learning Disabilities; Motor Skills; Multiple Sclerosis; Nervous System Diseases; Neurologic Examination; Neurologic Manifestations; Parkinson Disease; Time Factors; Tremor	1974
KR 339 in the treatment of Parkinsonian tremor. Acta neurologica Scandinavica, 1974, Volume: 50, Issue:4 Topics: Aged; Amantadine; Antiparkinson Agents; Blood Sedimentation; Bridged-Ring Compounds; Clinical Trials as Topic; Diethylamines; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Placebos; Time Factors; Tremor	1974
[Kr 339 in the treatment of parkinsonian tremor]. Duodecim; laaketieteellinen aikakauskirja, 1974, Volume: 90, Issue:8 Topics: Aged; Amantadine; Antiparkinson Agents; Bridged-Ring Compounds; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Placebos; Tremor	1974
[Principles for amantadine therapy in parkinsonism]. Lakartidningen, 1972, Nov-08, Volume: 69, Issue:46 Topics: Amantadine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Humans; Parkinson Disease; Placebos; Time Factors	1972
[Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes]. Revue neurologique, 1972, Volume: 127, Issue:2 Topics: Amantadine; Antiparkinson Agents; Dihydroxyphenylalanine; Drug Combinations; Drug Synergism; Humans; Parkinson Disease; Placebos; Thiothixene; Trihexyphenidyl	1972
Parkinson disease treated with a suspected dopamine receptor agonist. Archives of neurology, 1974, Volume: 30, Issue:5 Topics: Adult; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Benztropine; Dihydroxyphenylalanine; Dopamine; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Muscle Rigidity; Parkinson Disease; Piperazines; Placebos; Probenecid; Pyrimidines; Receptors, Cholinergic; Tremor; Trihexyphenidyl	1974
Comparison of amantadine, placebo, and levodopa in Parkinson's disease. Neurology, 1974, Volume: 24, Issue:8 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Motor Skills; Muscle Rigidity; Parkinson Disease; Placebos; Tremor	1974
L-dopa and amantadine in the therapy of parkinsonism. Wisconsin medical journal, 1969, Volume: 68, Issue:11 Topics: Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Synergism; Drug Tolerance; Female; Humans; Male; Middle Aged; Parkinson Disease	1969
Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Transactions of the American Neurological Association, 1969, Volume: 94 Topics: Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos	1969
L-dopa and amantadine hydrochloride in Parkinson's disease. Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1971, Volume: 4, Issue:3 Topics: Adult; Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Disability Evaluation; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Parkinson Disease	1971
[Results of two new drugs in Parkinson's disease: L-dopa and amantadine]. Revue neurologique, 1970, Volume: 122, Issue:2 Topics: Adult; Aged; Amantadine; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Middle Aged; Parkinson Disease; Parkinson Disease, Postencephalitic	1970
Amantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over study. Canadian Medical Association journal, 1971, Jul-10, Volume: 105, Issue:1 Topics: Age Factors; Alkaline Phosphatase; Amantadine; Blood Glucose; Blood Urea Nitrogen; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Female; Humans; L-Lactate Dehydrogenase; Lactose; Male; Parasympatholytics; Parkinson Disease; Placebos; Sex Factors; Time Factors; Uric Acid; White People	1971
Amantadine for Parkinson's disease. Neurology, 1971, Volume: 21, Issue:9 Topics: Aged; Amantadine; Amines; Brain; Clinical Trials as Topic; Dihydroxyphenylalanine; Disability Evaluation; Electroencephalography; Female; Humans; Male; Middle Aged; Movement Disorders; Muscular Diseases; Parkinson Disease; Placebos; Tremor	1971
Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine. Synapse (New York, N.Y.), 1999, Dec-15, Volume: 34, Issue:4 Topics: Adult; Amantadine; Antiparkinson Agents; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine Agents; Enzyme Activation; Female; Fluorine Radioisotopes; Frontal Lobe; Humans; Kinetics; Linear Models; Male; Neostriatum; Receptors, N-Methyl-D-Aspartate; Time Factors; Tomography, Emission-Computed	1999

Other Studies

137 other study(ies) available for amantadine and dihydroxyphenylalanine

Article	Year
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds. Pharmaceutical research, 2014, Volume: 31, Issue:4 Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation	2014
[Problematic long-term therapy of Parkinson's syndrome using amantadine salts]. Die Medizinische Welt, 1975, Nov-28, Volume: 26, Issue:48 Topics: Amantadine; Antidepressive Agents; Dihydroxyphenylalanine; Drug Therapy, Combination; Humans; Long-Term Care; Parkinson Disease; Tranquilizing Agents	1975
[Catecholamine excretion and treatment of parkinsonism with midantan]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1976, Volume: 76, Issue:9 Topics: Adult; Aged; Amantadine; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Female; Humans; Male; Middle Aged; Norepinephrine; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary	1976
[The antiparkinson activity of gludantan (preliminary report)]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1975, Volume: 75, Issue:6 Topics: Adult; Aged; Amantadine; Antiparkinson Agents; Dihydroxyphenylalanine; Humans; Middle Aged; Parkinson Disease	1975
Drug treatment of the neuroleptic malignant syndrome. Psychopharmacology bulletin, 1991, Volume: 27, Issue:3 Topics: Amantadine; Bromocriptine; Dantrolene; Dihydroxyphenylalanine; Dopamine Agents; Humans; Neuroleptic Malignant Syndrome	1991
Treatment of Parkinson's disease with amantadine and levodopa. A one-year study. Lancet (London, England), 1971, May-29, Volume: 1, Issue:7709 Topics: Aged; Amantadine; Blood Vessels; Dihydroxyphenylalanine; Edema; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Phenylacetates; Pigmentation Disorders; Skin; Water-Electrolyte Balance	1971
Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants. Neuropharmacology, 1973, Volume: 12, Issue:5 Topics: Amantadine; Amphetamine; Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hydroxydopamines; Male; Mice; Neurochemistry; Norepinephrine; Serotonin; Time Factors	1973
Central nervous system and autonomic nervous system effects of amantadine and of some standard anti-Parkinson drugs. Pharmacology, 1973, Volume: 10, Issue:4 Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Autonomic Nervous System; Body Temperature; Carbachol; Central Nervous System; Dihydroxyphenylalanine; Drug Interactions; Gastrointestinal Motility; Male; Mecamylamine; Mice; Mydriatics; Nicotine; Oxotremorine; Phenothiazines; Pupil; Rats; Trihexyphenidyl	1973
Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum. The Journal of pharmacy and pharmacology, 1974, Volume: 26, Issue:4 Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Choline; Corpus Striatum; Desipramine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Piperazines; Rats; Time Factors; Trihexyphenidyl	1974
[Syndrome involving the extrapyramidal motor systems and their drug treatment]. Fortschritte der Medizin, 1974, Aug-08, Volume: 92, Issue:22 Topics: Amantadine; Antiparkinson Agents; Basal Ganglia Diseases; Dihydroxyphenylalanine; gamma-Aminobutyric Acid; Humans; Hyperkinesis; Myoclonus; Parasympatholytics; Parkinson Disease; Penicillamine; Syndrome; Tranquilizing Agents	1974
Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat. European journal of pharmacology, 1974, Volume: 29, Issue:1 Topics: Amantadine; Analgesics, Opioid; Animals; Antiparkinson Agents; Apomorphine; Atropine; Benserazide; Benzyl Compounds; Catatonia; Dextroamphetamine; Dextromoramide; Dihydroxyphenylalanine; Dioxoles; Dose-Response Relationship, Drug; Humans; Male; Morphine; Piperazines; Pyrimidines; Rats; Time Factors; Trihexyphenidyl	1974
Amantadine in Parkinson's disease. Lancet (London, England), 1969, Aug-16, Volume: 2, Issue:7616 Topics: Amantadine; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Parkinson Disease	1969
Combined treatment of Parkinson's disease with amantadine and L-dopa. Lancet (London, England), 1970, Jun-27, Volume: 1, Issue:7661 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1970
Mental symptoms in parkinsonian patients treated with L-dopa. Lancet (London, England), 1970, Oct-03, Volume: 2, Issue:7675 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Humans; Male; Parkinson Disease	1970
Parkinsonism. The Medical journal of Australia, 1970, Apr-11, Volume: 1, Issue:15 Topics: Amantadine; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Humans; Nerve Endings; Parasympatholytics; Parkinson Disease; Stereotaxic Techniques; Synaptic Transmission	1970
The rigid form of Huntington's chorea. Neurology, 1971, Volume: 21, Issue:3 Topics: Adult; Age Factors; Amantadine; Dihydroxyphenylalanine; Female; Humans; Huntington Disease; Movement Disorders; Pedigree; Pyridoxine; Sleep, REM; Spasm	1971
[Electrophysiological findings during treatment of the parkinsonian syndrome with amantadine]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Amantadine; Brain; Dihydroxyphenylalanine; Electrophysiology; Facial Nerve; Humans; Parkinson Disease; Reflex; Sleep, REM	1971
Habituation of blink reflexes in parkinsonian patients under levodopa and amantadine treatment. Journal of the neurological sciences, 1972, Volume: 17, Issue:2 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Electromyography; Eye Movements; Female; Habituation, Psychophysiologic; Humans; Male; Middle Aged; Parkinson Disease; Reflex; Synaptic Transmission	1972
Dysaesthesia-dyskinesia: a syndrome of painful legs and moving toes. Proceedings of the Australian Association of Neurologists, 1973, Volume: 9 Topics: Aged; Amantadine; Amitriptyline; Chlorpromazine; Dihydroxyphenylalanine; Female; Humans; Leg; Movement Disorders; Peripheral Nervous System Diseases; Sensation; Syndrome; Toes	1973
L-Dopa therapy in Parkinson's disease. The Journal of the Florida Medical Association, 1970, Volume: 57, Issue:6 Topics: Amantadine; Dihydroxyphenylalanine; Histamine H1 Antagonists; Humans; Parasympatholytics; Parkinson Disease	1970
Potentiation by amantadine hydrochloride of L-dopa-induced effects in mice. The Journal of pharmacy and pharmacology, 1970, Volume: 22, Issue:8 Topics: Amantadine; Animals; Behavior, Animal; Dihydroxyphenylalanine; Drug Synergism; Female; Mice; Motor Activity	1970
On the mode of action of amantadine. The Journal of pharmacy and pharmacology, 1970, Volume: 22, Issue:12 Topics: Amantadine; Amphetamine; Animals; Brain Chemistry; Dihydroxyphenylalanine; Dopamine; Methyltyrosines; Mice; Motor Activity; Myocardium; Nialamide	1970
Parkinsonism. Journal of the American Pharmaceutical Association, 1972, Volume: 12, Issue:1 Topics: Amantadine; Dihydroxyphenylalanine; Histamine H1 Antagonists; Humans; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Physical Therapy Modalities	1972
Differences in the locomotor activity of mice as measured by an Animex and photoresis to actometer. The Journal of pharmacy and pharmacology, 1971, Volume: 23, Issue:12 Topics: Amantadine; Animals; Dihydroxyphenylalanine; Locomotion; Methyltyrosines; Mice; Motor Activity; Phenoxybenzamine; Reserpine	1971
Treatment of parkinsonism. The New England journal of medicine, 1972, Nov-16, Volume: 287, Issue:20 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease; Phenothiazines; Propranolol	1972
Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy. Folia psychiatrica et neurologica japonica, 1974, Volume: 28, Issue:1 Topics: Adult; Aged; Amantadine; Dihydroxyphenylalanine; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease; Thalamus	1974
Dopamine receptor in the reward system of the rat. Archives internationales de pharmacodynamie et de therapie, 1974, Volume: 209, Issue:2 Topics: Amantadine; Animals; Apomorphine; Benzyl Compounds; Cortical Synchronization; Desipramine; Dihydroxyphenylalanine; Dopamine; Electrodes, Implanted; Electroencephalography; Haloperidol; Hydrazines; Hypothalamus; Levodopa; Male; Rats; Receptors, Drug; Reward; Self Stimulation; Time Factors	1974
The effect of delta9-tetrahydrocannabinol on the uptake and release of 14C-dopamine from crude striatal synaptosoma; preparations. Neuropharmacology, 1974, Volume: 13, Issue:12 Topics: Amantadine; Amphetamine; Animals; Cannabis; Carbon Radioisotopes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Dronabinol; Ephedrine; Male; Mice; Pargyline; Synaptosomes	1974
Advances in the treatment of parkinsonism. Midwife and health visitor, 1972, Volume: 8, Issue:6 Topics: Amantadine; Dihydroxyphenylalanine; Parasympatholytics; Parkinson Disease	1972
Amantadine and L-dopa. Australian and New Zealand journal of medicine, 1972, Volume: 2, Issue:3 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1972
Effects of L-dopa on plasma growth hormones and insulin. Acta neurologica Scandinavica. Supplementum, 1972, Volume: 51 Topics: Administration, Oral; Amantadine; Blood Glucose; Dihydroxyphenylalanine; Growth Hormone; Humans; Injections, Intravenous; Insulin; Nervous System Diseases; Parkinson Disease; Radioimmunoassay; Stimulation, Chemical	1972
Possible association between triphasic E.E.G. waves and disorder of dopaminergic systems. British medical journal, 1973, Aug-04, Volume: 3, Issue:5874 Topics: Amantadine; Cerebrovascular Disorders; Creutzfeldt-Jakob Syndrome; Dihydroxyphenylalanine; Dopamine; Electroencephalography; Female; Humans	1973
The effect of -methyl-p-tyrosine and substantia nigra lesions on spinal motor activity in the rat. European journal of pharmacology, 1972, Volume: 20, Issue:3 Topics: Action Potentials; Amantadine; Animals; Atropine; Dihydroxyphenylalanine; Electrocoagulation; Electromyography; Hydroxydopamines; Methamphetamine; Methyltyrosines; Microinjections; Motor Activity; Motor Neurons; Rats; Reflex; Spinal Nerves; Substantia Nigra	1972
[Amantadine therapy in parkinsonism]. Lakartidningen, 1972, Nov-08, Volume: 69, Issue:46 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1972
[The functional role of amantadine]. Lakartidningen, 1972, Nov-08, Volume: 69, Issue:46 Topics: Amantadine; Animals; Central Nervous System; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Humans; Mice; Motor Activity; Norepinephrine; Parkinson Disease; Rats; Stimulation, Chemical	1972
[Surgical treatment of parkisonism in the light of the modern medical therapy]. Lakartidningen, 1972, Nov-08, Volume: 69, Issue:46 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease; Prognosis; Tremor	1972
[Therapy of parkinsonism using L-dopa. I]. Zeitschrift fur arztliche Fortbildung, 1972, Dec-01, Volume: 66, Issue:23 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Hydrazines; Monoamine Oxidase Inhibitors; Parkinson Disease	1972
Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and Parkinsonian subjects. Journal of the neurological sciences, 1972, Volume: 17, Issue:3 Topics: Adult; Aged; Amantadine; Catecholamines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Female; Histamine; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Norepinephrine; Parkinson Disease; Phenylacetates	1972
Effect of chronic drug treatment on intestinal membrane transport of 14 C-L-dopa. British journal of pharmacology, 1972, Volume: 46, Issue:4 Topics: Amantadine; Animals; Biological Transport; Carbon Isotopes; Chlorpromazine; Dihydroxyphenylalanine; Drug Interactions; In Vitro Techniques; Intestinal Absorption; Jejunum; Male; Neomycin; Phenobarbital; Rats	1972
[Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes]. Revue neurologique, 1972, Volume: 127, Issue:2 Topics: Amantadine; Brain; Dihydroxyphenylalanine; Electroencephalography; Humans; Parkinson Disease	1972
[Drug therapy of Parkinson's diseases]. Acquisitions medicales recentes, 1972 Topics: Amantadine; Dihydroxyphenylalanine; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Mental Disorders; Parasympatholytics; Parkinson Disease	1972
Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects. British journal of pharmacology, 1972, Volume: 44, Issue:2 Topics: Amantadine; Amines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Histamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Norepinephrine; Parkinson Disease; Phenylacetates	1972
Action of L-dopa, norepinephrine and amantadine on ulcers caused by reserpine in the rat. Digestion, 1972, Volume: 7, Issue:5 Topics: Administration, Oral; Amantadine; Animals; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Hypothermia; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Norepinephrine; Phenylbutazone; Rats; Reserpine; Stomach Ulcer; Time Factors	1972
Amantadine in Parkinson's disease. Review of more than two years' experience. JAMA, 1972, Nov-13, Volume: 222, Issue:7 Topics: Aged; Amantadine; Ataxia; Constipation; Depression; Diarrhea; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Headache; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Time Factors; Tremor	1972
L-dopa for parkinsonism. Geriatrics, 1973, Volume: 28, Issue:1 Topics: Aged; Amantadine; Depression; Dihydroxyphenylalanine; Female; Follow-Up Studies; Hallucinations; Humans; Hypertension; Male; Middle Aged; Movement Disorders; Parkinson Disease; Sleep Wake Disorders; Time Factors	1973
[Amantadine therapy in parkinsonism]. Ugeskrift for laeger, 1973, Jan-15, Volume: 135, Issue:3 Topics: Amantadine; Dihydroxyphenylalanine; Drug Synergism; Humans; Parasympatholytics; Parkinson Disease	1973
The effect of amantadine on radiolabeled biogenic amines in the rat brain. European journal of pharmacology, 1973, Volume: 21, Issue:2 Topics: Amantadine; Animals; Biogenic Amines; Brain; Brain Chemistry; Carbon Isotopes; Chromatography, Paper; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Injections; Iproniazid; Male; Monoamine Oxidase; Norepinephrine; Rats; Serotonin; Synaptosomes; Tritium	1973
The effect of antiparkinson drugs on the liguomandibular reflex in cats. European journal of pharmacology, 1973, Volume: 21, Issue:2 Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Cats; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Haloperidol; Lingual Nerve; Mandibular Nerve; Phenoxybenzamine; Receptors, Drug; Reflex	1973
Levodopa and related drugs. The Medical letter on drugs and therapeutics, 1973, Mar-02, Volume: 15, Issue:5 Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Pyridoxine	1973
Interactions of L-dopa and amantadine in patients with Parkinsonism. Journal of neurology, neurosurgery, and psychiatry, 1973, Volume: 36, Issue:3 Topics: Amantadine; Dihydroxyphenylalanine; Drug Interactions; Evaluation Studies as Topic; Female; Homovanillic Acid; Humans; Male; Middle Aged; Muscle Rigidity; Muscles; Parkinson Disease; Tremor	1973
L-dopa level in plasma, primary condition for the kinetic effect. Journal of neural transmission, 1973, Volume: 34, Issue:2 Topics: Administration, Oral; Aged; Amantadine; Aromatic Amino Acid Decarboxylase Inhibitors; Biopharmaceutics; Brain; Dihydroxyphenylalanine; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Hydrazines; Injections, Intravenous; Male; Motor Activity; Parkinson Disease	1973
Plasma growth hormone and insulin response to levodopa and amantadine. Journal of neural transmission, 1973, Volume: 34, Issue:2 Topics: Administration, Oral; Amantadine; Blood Glucose; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Injections, Intravenous; Insulin; Male; Middle Aged; Parkinson Disease; Pituitary Gland	1973
Permanent dementia in idiopathic Parkinsonism treated with levodopa. Archives of neurology, 1973, Volume: 29, Issue:4 Topics: Aged; Amantadine; Brain; Dihydroxyphenylalanine; Electroencephalography; Humans; Male; Parkinson Disease; Psychoses, Substance-Induced; Pyridoxine; Trihexyphenidyl	1973
[Favorable results with an association of L-dopa and amantadine added to penicillamine in the treatment of Wilson's disease]. Minerva pediatrica, 1973, May-19, Volume: 25, Issue:18 Topics: Adolescent; Amantadine; Dihydroxyphenylalanine; Drug Synergism; Female; Hepatolenticular Degeneration; Humans; Penicillamine	1973
Sporadic and familial parkinsonism and motor neuron disease. Neurology, 1973, Volume: 23, Issue:9 Topics: Aged; Amantadine; Amyotrophic Lateral Sclerosis; Cerebellar Diseases; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Encephalitis; Female; Humans; Male; Middle Aged; Muscles; Nerve Degeneration; Norepinephrine; Parkinson Disease; Serotonin; Spinal Cord Diseases; Trihexyphenidyl	1973
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine. British journal of pharmacology, 1973, Volume: 47, Issue:3 Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain Chemistry; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Hydroxydopamines; Methylphenidate; Methyltyrosines; Rats; Reserpine; Scopolamine	1973
Amantadine in the treatment of Parkinsonism and related diseases. JAMA, 1973, Feb-26, Volume: 223, Issue:9 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1973
[Combined therapy of parkinsonism using amantadine]. Munchener medizinische Wochenschrift (1950), 1973, Apr-06, Volume: 115, Issue:14 Topics: Amantadine; Dihydroxyphenylalanine; Drug Combinations; Humans; Parkinson Disease	1973
[Therapy of Parkinson's syndrome]. Die Medizinische Welt, 1973, Jun-08, Volume: 24, Issue:23 Topics: Amantadine; Blood-Brain Barrier; Dihydroxyphenylalanine; Humans; Hypotension; Parkinson Disease	1973
Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative. European journal of pharmacology, 1973, Volume: 23, Issue:3 Topics: Amantadine; Animals; Antiparkinson Agents; Behavior, Animal; Brain; Brain Chemistry; Catecholamines; Central Nervous System; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Male; Mice; Motor Activity; Myocardium; Norepinephrine; Normetanephrine; Rats; Receptors, Drug; Reflex; Time Factors; Tyramine	1973
Effect of amantadine on L-2-14C-dopa metabolism in parkinsonism. Life sciences, 1973, Aug-16, Volume: 13, Issue:3 Topics: Administration, Oral; Aged; Amantadine; Carbon Radioisotopes; Carboxylic Acids; Catecholamines; Chromatography, Ion Exchange; Dihydroxyphenylalanine; Humans; Male; Middle Aged; Parkinson Disease; Phenols; Time Factors	1973
[Present-day treatment of parkinsonism in the aged]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1973, Oct-02, Volume: 62, Issue:40 Topics: Aged; Amantadine; Antiparkinson Agents; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Humans; Middle Aged; Parkinson Disease; Trihexyphenidyl	1973
[Therapy of akinetic crises]. Die Medizinische Welt, 1973, Aug-24, Volume: 24, Issue:33 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Paralysis; Parkinson Disease	1973
Amantadine enhancement of L-DOPA induced growth hormone stimulation. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1973, Volume: 5, Issue:6 Topics: Adult; Amantadine; Blood Glucose; Dihydroxyphenylalanine; Drug Synergism; Fatty Acids, Nonesterified; Female; Growth Hormone; Humans; Iodine Radioisotopes; Male; Menstruation; Middle Aged; Parkinson Disease; Stimulation, Chemical; Time Factors	1973
[Current medical treatment of Parkinsonian syndromes]. Revue roumaine de neurologie, 1973, Volume: 10, Issue:4 Topics: Adult; Age Factors; Aged; Amantadine; Antiparkinson Agents; Dihydroxyphenylalanine; Drug Combinations; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Parkinson Disease, Secondary	1973
Inhibition of the apomorphine gnawing compulsion by amantadine. Experientia, 1973, Volume: 29, Issue:12 Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Chlorpromazine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Synergism; Male; Metoclopramide; Rats	1973
[Accomplishment of the treatment and evaluation of treatment alternatives in parkinsonism]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1973, Oct-10, Volume: 93, Issue:28 Topics: Administration, Oral; Amantadine; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Humans; Parasympatholytics; Parkinson Disease	1973
[Epidemic tremor in chickens as a model for the testing of antiparkinson drugs]. Acta biologica et medica Germanica, 1973, Volume: 31, Issue:3 Topics: Amantadine; Animals; Antiparkinson Agents; Chickens; Dihydroxyphenylalanine; Disease Models, Animal; Hydroxybutyrates; Tremor	1973
Responses of the urinary excretion of homovanillic acid and of 5-hydroxy-indol-acetic acid to treatment with L-dopa and amantadine. Therapia Hungarica (English edition), 1973, Volume: 21, Issue:1 Topics: Amantadine; Dihydroxyphenylalanine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Parkinson Disease; Phenylacetates	1973
[Results obtained with L-DOPA and amantadine in the treatment of patients with disorders of consciousness and of the vigilant state]. L'Ateneo parmense. Acta bio-medica : organo della Societa di medicina e scienze naturali di Parma, 1973, Volume: 44, Issue:5 Topics: Adult; Aged; Amantadine; Attention; Brain Diseases; Brain Injuries; Brain Neoplasms; Cognition Disorders; Contusions; Dihydroxyphenylalanine; Female; Hematoma; Humans; Male; Middle Aged; Sleep Wake Disorders	1973
Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats. European journal of pharmacology, 1973, Volume: 24, Issue:1 Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Dextroamphetamine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Rats; Statistics as Topic; Stereotyped Behavior; Time Factors	1973
Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors. Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1973, Volume: 6, Issue:3 Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Body Temperature; Brain Chemistry; Catalepsy; Depression, Chemical; Desipramine; Dextroamphetamine; Dihydroxyphenylalanine; Disulfides; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Exploratory Behavior; Humans; Hydrazines; Hypnotics and Sedatives; Male; Methyltyrosines; Motor Activity; Norepinephrine; Posture; Rats; Receptors, Drug; Scopolamine; Time Factors	1973
Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations. Journal of neuropathology and experimental neurology, 1974, Volume: 33, Issue:1 Topics: Aged; Amantadine; Brain; Brain Diseases; Bulbar Palsy, Progressive; Dementia; Dihydroxyphenylalanine; Female; Humans; Mesencephalon; Microtubules; Middle Aged; Nerve Degeneration; Neurofibrils; Olivary Nucleus; Ophthalmoplegia; Parkinson Disease, Postencephalitic; Pons; Spinal Cord; Substantia Nigra; Trihexyphenidyl	1974
[Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)]. Medizinische Klinik, 1974, Mar-29, Volume: 69, Issue:13 Topics: Aged; Amantadine; Carboxy-Lyases; Dihydroxyphenylalanine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease; Premedication; Sulfates	1974
[Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)]. Archiv fur Psychiatrie und Nervenkrankheiten, 1974, Apr-09, Volume: 218, Issue:4 Topics: Amantadine; Anesthetics; Anti-Bacterial Agents; Antidepressive Agents; Antihypertensive Agents; Antiparkinson Agents; Atropa belladonna; Depression; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypertension; Iatrogenic Disease; Parasympatholytics; Parkinson Disease; Plants, Medicinal; Plants, Toxic; Pyridoxine; Sympathomimetics; Tranquilizing Agents; Tropanes	1974
Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease. Journal of neurology, neurosurgery, and psychiatry, 1974, Volume: 37, Issue:4 Topics: Aged; Amantadine; Cognition Disorders; Dihydroxyphenylalanine; Drug Therapy, Combination; Edema; Eye Movements; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Parkinson Disease, Postencephalitic; Trihexyphenidyl; Xerostomia	1974
The effect of amantadine, L-dopa, (plus)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response. Neuropharmacology, 1974, Volume: 13, Issue:3 Topics: Amantadine; Animals; Apomorphine; Avoidance Learning; Conditioning, Psychological; Depression, Chemical; Dextroamphetamine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Male; Memory; Rats; Stimulation, Chemical; Time Factors	1974
Amantadine hydrochloride: alteration in peripheral circulation. Neurology, 1974, Volume: 24, Issue:1 Topics: Aged; Amantadine; Aspartate Aminotransferases; Blood Cell Count; Blood Circulation; Dihydroxyphenylalanine; Edema; Female; Fingers; Humans; Male; Middle Aged; Parkinson Disease; Plethysmography; Skin Temperature; Toes; Vascular Diseases; Vasoconstrictor Agents	1974
Polysynaptic spinal reflexes in Parkinson's disease. Neurology, 1974, Volume: 24, Issue:9 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Drug Combinations; Electromyography; Female; Humans; Male; Middle Aged; Muscle Contraction; Pain; Parkinson Disease; Reaction Time; Reflex, Abnormal; Spinal Cord; Tibial Nerve	1974
The therapeutic possibilities of L-dopa and amantadine in Parkinsonian patients who have undergone bilateral thalamotomy. European neurology, 1971, Volume: 5, Issue:5 Topics: Adolescent; Adult; Aged; Amantadine; Child; Dihydroxyphenylalanine; Electroencephalography; Female; Humans; Male; Middle Aged; Movement Disorders; Parkinson Disease; Stereotaxic Techniques; Thalamus; Tremor; Verbal Behavior	1971
[Treatment of parkinsonian states with L-dopa]. Bulletin de l'Academie nationale de medecine, 1971, Nov-09, Volume: 155, Issue:28 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1971
[Amantadine. Prolonged clinical trial in 50 parkinsonian patients]. La Nouvelle presse medicale, 1972, Feb-19, Volume: 1, Issue:8 Topics: Adult; Aged; Amantadine; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Imipramine; Male; Middle Aged; Parkinson Disease	1972
[Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease]. Schweizerische medizinische Wochenschrift, 1972, Apr-22, Volume: 102, Issue:16 Topics: Adult; Aged; Amantadine; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Male; Middle Aged; Parkinson Disease	1972
Treatment of Parkinson's disease. The Journal of the Kentucky Medical Association, 1972, Volume: 70, Issue:4 Topics: Amantadine; Counseling; Dihydroxyphenylalanine; Humans; Neurologic Manifestations; Parkinson Disease	1972
[The treatment of Parkinson's disease with levodopa. Principles. Practical advice. Considerations]. La Nouvelle presse medicale, 1972, Mar-04, Volume: 1, Issue:10 Topics: Amantadine; Dihydroxyphenylalanine; Drug Combinations; Drug Interactions; Drug Tolerance; Female; Hospitalization; Humans; Male; Methods; Parkinson Disease; Parkinson Disease, Postencephalitic	1972
[Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases]. La Nouvelle presse medicale, 1972, Apr-29, Volume: 1, Issue:18 Topics: Amantadine; Animals; Dihydroxyphenylalanine; Drug Synergism; Humans; Mice; Parkinson Disease	1972
Levodopa and amantadine in the treatment of Parkinsonism. The Practitioner, 1972, Volume: 208, Issue:246 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Movement Disorders; Nausea; Parkinson Disease; Psychoses, Substance-Induced	1972
Clinical manifestations of essential tremor. Journal of neurology, neurosurgery, and psychiatry, 1972, Volume: 35, Issue:3 Topics: Adult; Aged; Amantadine; Ataxia; Chlordiazepoxide; Dihydroxyphenylalanine; Female; Humans; Male; Mephenesin; Middle Aged; Movement Disorders; Nerve Degeneration; Parkinson Disease; Sweating; Tremor	1972
[Attempt at Larodopa and Viregyt treatment in a case of progressive supranuclear palsy]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 1972, Jul-01, Volume: 25, Issue:11 Topics: Amantadine; Cerebral Palsy; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Middle Aged	1972
[Current treatment of Parkinsonism with amantadine hydrochloride]. Polski tygodnik lekarski (Warsaw, Poland : 1960), 1972, Jul-03, Volume: 27, Issue:23 Topics: Amantadine; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Middle Aged; Parkinson Disease	1972
The effect of amantadine on motor activity and catalepsy in rats. Psychopharmacologia, 1972, Volume: 24, Issue:2 Topics: Amantadine; Animals; Brain; Catalepsy; Catecholamines; Chlorpromazine; Cocaine; Desipramine; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Male; Methyltyrosines; Motor Activity; Nialamide; Rats; Rats, Inbred Strains; Reserpine; Spiro Compounds; Thiocarbamates	1972
[Medical treatment of Parkinson's disease]. Annales de medecine interne, 1972, Volume: 123, Issue:4 Topics: Amantadine; Carboxy-Lyases; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease; Phenothiazines; Pyridoxine; Reserpine	1972
[Treatment of Parkinson syndrome in general practice]. Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1972, Oct-03, Volume: 61, Issue:40 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Family Practice; Humans; Male; Parkinson Disease; Psychotherapy	1972
L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride. Geriatrics, 1971, Volume: 26, Issue:8 Topics: Aged; Amantadine; Chlorides; Depression; Dihydroxyphenylalanine; Drug Hypersensitivity; Female; Follow-Up Studies; Hallucinations; Humans; Hyperkinesis; Hypnotics and Sedatives; Hypotension; Male; Middle Aged; Nausea; Parasympatholytics; Parkinson Disease; Sympathomimetics; Vomiting	1971
[Amantadine in Parkinson's disease]. La Clinica terapeutica, 1971, Jun-15, Volume: 57, Issue:5 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1971
[Action of amantadine HCl alone and in combination with L-dopa on parkinsonism]. Medizinische Monatsschrift, 1971, Volume: 25, Issue:10 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Drug Synergism; Electroencephalography; Electromyography; Female; Humans; Middle Aged; Parkinson Disease	1971
[Preliminary results of the use of amantadine in parkinsonian syndromes]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Adult; Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease	1971
[Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Affective Symptoms; Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease; Psychotic Disorders	1971
[6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease	1971
[Clinical results of the intravenous administration of amantadine in patients with parkinsonism]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Injections, Intravenous; Parkinson Disease	1971
[Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Amantadine; Anxiety; Depression; Dihydroxyphenylalanine; Emotions; Humans; Intelligence Tests; Mental Processes; Motivation; Parkinson Disease; Psychological Tests	1971
[Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease; Psychomotor Disorders	1971
[The addition of amantadine to prolonged treatment with L-Dopa. Considerations on 20 cases]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Adolescent; Adult; Aged; Amantadine; Child; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease	1971
[Amantadine and L-Dopa in the treatment of parkinsonian syndromes]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1971
[Therapeutic association of amantadine and L-Dopa in parkinsonism]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1971
[Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Adult; Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease	1971
[Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1971
[Prolonged treatment of Parkinson's disease with amantadine and L-Dopa]. Minerva medica, 1971, Oct-31, Volume: 62, Issue:82 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease; Time Factors	1971
[Modern therapeutics of Parkinson's disease]. Lyon medical, 1971, Nov-14, Volume: 226, Issue:17 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1971
[Conservative therapy in the Parkinson syndrome]. Wiener medizinische Wochenschrift (1946), 1971, Nov-13, Volume: 121, Issue:46 Topics: Amantadine; Antidepressive Agents; Dihydroxyphenylalanine; Humans; Imipramine; Injections, Intravenous; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Time Factors	1971
[Treatment of the Parkinson syndrome with amantadine]. Schweizerische medizinische Wochenschrift, 1971, Dec-04, Volume: 101, Issue:48 Topics: Adult; Aged; Amantadine; Arteriosclerosis; Cognition Disorders; Dihydroxyphenylalanine; Drug Interactions; Female; Humans; Male; Middle Aged; Movement Disorders; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Spasm; Speech Disorders; Tremor	1971
Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice. Physiology & behavior, 1971, Volume: 6, Issue:4 Topics: Amantadine; Amitriptyline; Animals; Antiparkinson Agents; Atropine; Behavior, Animal; Dihydroxyphenylalanine; Diphenhydramine; Drug Synergism; Imipramine; Mice; Orphenadrine; Parasympatholytics; Pargyline; Trihexyphenidyl	1971
[Study of the central action of amantadine]. Il Farmaco; edizione pratica, 1971, Volume: 26, Issue:11 Topics: Amantadine; Animals; Butyrophenones; Central Nervous System; Chlorpromazine; Dihydroxyphenylalanine; Drug Antagonism; Drug Synergism; Electroencephalography; Epilepsy; Motor Activity; Rabbits; Rats; Reserpine	1971
Blink reflex studies in patients with Parkinsonism before and during therapy. Journal of neurology, neurosurgery, and psychiatry, 1971, Volume: 34, Issue:6 Topics: Amantadine; Dihydroxyphenylalanine; Electric Stimulation; Electromyography; Eye Movements; Habituation, Psychophysiologic; Humans; Parasympatholytics; Parkinson Disease; Reflex	1971
Non-resting tremor in Parkinson's disease. Transactions of the American Neurological Association, 1971, Volume: 96 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Humans; Male; Parkinson Disease; Propranolol; Tremor	1971
[Current therapeutics of Parkinson's disease]. Les Cahiers de medecine, 1971, Nov-15, Volume: 12, Issue:14 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Humans; Parkinson Disease	1971
Concurrent session: current trends in neurology and psychiatry. The Medical journal of Australia, 1971, Oct-02, Volume: 2, Issue:14 Topics: Amantadine; Behavior Therapy; Dihydroxyphenylalanine; Epilepsy; Female; Humans; Male; Neurology; Parkinson Disease; Psychiatry; Sexual Dysfunction, Physiological; Substance-Related Disorders; Therapeutic Community	1971
The management of parkinsonism. The New Zealand medical journal, 1971, Volume: 74, Issue:470 Topics: Amantadine; Dihydroxyphenylalanine; Drug Combinations; Drug Synergism; Humans; Parkinson Disease	1971
[Advancement on the area of antiparkinsonism drugs]. Bollettino chimico farmaceutico, 1969, Volume: 108, Issue:8 Topics: Amantadine; Amino Acids; Brain; Dihydroxyphenylalanine; Humans; Parkinson Disease; Phenylalanine	1969
A second report on Levodopa. The Medical letter on drugs and therapeutics, 1969, Sep-05, Volume: 11, Issue:18 Topics: Amantadine; Arrhythmias, Cardiac; Cerebrovascular Disorders; Dihydroxyphenylalanine; Humans; Hypotension, Orthostatic; Legislation, Drug; Movement Disorders; Nausea; Parkinson Disease; United States; United States Food and Drug Administration; Vomiting	1969
[Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease]. Minerva medica, 1970, Jul-04, Volume: 61, Issue:53 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease	1970
[The treatment of parkinsonism with amantadine]. Deutsche medizinische Wochenschrift (1946), 1970, Apr-24, Volume: 95, Issue:17 Topics: Adult; Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parasympatholytics; Parkinson Disease; Tremor	1970
The treatment of parkinsonism with L-Dopa and amantadine. The Journal of the Florida Medical Association, 1970, Volume: 57, Issue:6 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Parkinson Disease	1970
Specific therapy in Parkinson's disease. The Medical journal of Australia, 1970, Oct-03, Volume: 2, Issue:14 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Hypotension, Orthostatic; Nausea; Parkinson Disease; Vomiting	1970
Observations on the effect of amantadine hydrochloride in the treatment of Parkinsonism. The Medical journal of Australia, 1970, Oct-03, Volume: 2, Issue:14 Topics: Aged; Amantadine; Depression; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Muscle Tonus; Nausea; Parkinson Disease; Vertigo	1970
L-dopa and amantadine for Parkinsonism. Drug and therapeutics bulletin, 1970, Aug-14, Volume: 8, Issue:17 Topics: Amantadine; Dihydroxyphenylalanine; Drug Synergism; Humans; Parkinson Disease	1970
[Current perspectives in the treatment of Parkinson's disease]. Revue medicale de Liege, 1971, Feb-15, Volume: 26, Issue:4 Topics: Age Factors; Amantadine; Dihydroxyphenylalanine; Humans; Injections, Intravenous; Parkinson Disease; Prognosis	1971
[Current therapeutic problems of the parkinson syndrome]. Die Medizinische Welt, 1971, Aug-21, Volume: 33 Topics: Amantadine; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease	1971
L-dopa and amantadine hydrochloride in extra-pyramidal disorders. Postgraduate medical journal, 1971, Volume: 47, Issue:544 Topics: Adult; Aged; Amantadine; Brain Diseases; Dihydroxyphenylalanine; Extrapyramidal Tracts; Eye Movements; Female; Humans; Male; Middle Aged	1971
Differentiation of tardive dyskinesias and drug-induced Parkinsonism. The New England journal of medicine, 1971, Jun-17, Volume: 284, Issue:24 Topics: Amantadine; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Hyperkinesis; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary	1971
Amantadine in the treatment of Parkinson's disease. JAMA, 1969, May-19, Volume: 208, Issue:7 Topics: Aged; Amantadine; Dihydroxyphenylalanine; Drug Synergism; Humans; Male; Parkinson Disease	1969
Parkinson's disease and amantadine hydrochloride. JAMA, 1969, May-19, Volume: 208, Issue:7 Topics: Amantadine; Dihydroxyphenylalanine; Drug Synergism; Humans; Parkinson Disease	1969
New approaches in the treatment of parkinsonism. JAMA, 1969, Sep-01, Volume: 209, Issue:9 Topics: Acetylcholine; Amantadine; Blood-Brain Barrier; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Female; Humans; Hydrazines; Parkinson Disease	1969
[Therapeutic measures in tardive dyskinesia]. Fortschritte der Neurologie-Psychiatrie, 1983, Volume: 51, Issue:6 Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dihydroxyphenylalanine; Dyskinesia, Drug-Induced; Humans; Phosphatidylcholines; Schizophrenia; Valproic Acid	1983
Morphine enhances high-affinity choline uptake in mouse striatum. Pharmacology, biochemistry, and behavior, 1982, Volume: 17, Issue:3 Topics: Amantadine; Animals; Behavior, Animal; Choline; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Haloperidol; Male; Mice; Morphine; Sodium	1982
[Treatment of Parkinson disease]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1982, Sep-10, Volume: 71, Issue:9 Topics: Amantadine; Dihydroxyphenylalanine; Drug Therapy, Combination; Ergot Alkaloids; Humans; Levodopa; Parkinson Disease	1982
[Physico-chemical properties of borate derivatives of DOPA, dopamine, and their liposome forms]. Bioorganicheskaia khimiia, 1998, Volume: 24, Issue:11 Topics: Amantadine; Borates; Catechols; Dihydroxyphenylalanine; Dopamine; Kinetics; Liposomes; Magnetic Resonance Spectroscopy; Phosphatidylcholines; Quaternary Ammonium Compounds	1998